Description and In-Vitro Test Results of a New Wearable/Portable Device for Extracorporeal Blood Ultrafiltration
Paolo Boscariol,
Giovanni Boschetti,
Aldo Dalla Via,
Nicola De Rossi,
Mauro Neri,
Ilaria Palomba,
Dario Richiedei,
Claudio Ronco,
Alberto Trevisani
Affiliations
Paolo Boscariol
Department of Management and Engineering, University of Padova, 36100 Vicenza, Italy
Giovanni Boschetti
Department of Management and Engineering, University of Padova, 36100 Vicenza, Italy
Aldo Dalla Via
Department of Management and Engineering, University of Padova, 36100 Vicenza, Italy
Nicola De Rossi
Department of Management and Engineering, University of Padova, 36100 Vicenza, Italy
Mauro Neri
Department of Management and Engineering, University of Padova, 36100 Vicenza, Italy
Ilaria Palomba
Faculty of Science and Technology, Free University of Bozen/Bolzano, 39100 Bolzano, Italy
Dario Richiedei
Department of Management and Engineering, University of Padova, 36100 Vicenza, Italy
Claudio Ronco
Department of Nephrology, Dialysis and Transplantation and International Renal Research Institute of Vicenza (IIRIV), S. Bortolo Hospital, 36100 Vicenza, Italy
Alberto Trevisani
Department of Management and Engineering, University of Padova, 36100 Vicenza, Italy
This paper presents the design of Rene Artificiale Portatile (RAP), a novel wearable and portable device for extracorporeal blood ultrafiltration, capable of providing remote treatment of fluid overload in patients with kidney diseases and/or congestive heart failure. The development of the device is based on a new design paradigm, since the layout of the device is box-shaped, as to fit a backpack or a trolley case, differentiating it from other existing devices. The efficient layout and component placement guarantee minimalization and ergonomics, as well as an efficient and cost-effective use. The redundant control architecture of the device has been implemented to ensure a high level of safety and an effective implementation of the clinical treatment. The consistency of the design and its effective implementation are assessed by the results of the preliminary in-vitro tests presented and discussed in this work.
